• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

$65 billion investment needed to combat climate health crisis by 2050

, 19 February 2025/in Climate Change, E-News, Sustainability /by panglobal

A major investment in medical innovation could prevent 6.5 million deaths and save $5.8 trillion in economic losses from climate-related health impacts over the next 25 years, according to a comprehensive new analysis from the World Economic Forum.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/climate-change-17-2.jpg 287 480 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-19 06:00:142025-02-17 05:51:54$65 billion investment needed to combat climate health crisis by 2050

Classical music stabilises foetal heart rate patterns, study reveals

, 18 February 2025/in E-News, Editors' Picks, Obs Gyn /by panglobal

Classical music exposure during pregnancy leads to more stable and predictable fatal heart rate patterns, according to groundbreaking research that explores the relationship between musical stimuli and foetal cardiac response using advanced mathematical analysis.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/foetal-music.jpg 324 551 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-18 06:00:312025-02-17 05:41:00Classical music stabilises foetal heart rate patterns, study reveals

AI system designs peptides to target previously ‘undruggable’ proteins

, 16 February 2025/in AI, E-News, pharmacology /by panglobal

Biomedical engineers at Duke University have developed an artificial intelligence platform that can design short proteins capable of binding to and destroying previously untreatable disease-causing proteins. The breakthrough could revolutionise drug development for currently intractable diseases.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/PepPrCLIP.jpeg 1106 1779 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-16 06:00:422025-02-06 07:05:36AI system designs peptides to target previously ‘undruggable’ proteins

Updated guidelines strengthen care standards for transfusion-dependent thalassaemia

, 13 February 2025/in E-News, haematology /by panglobal

The Thalassaemia International Federation (TIF) has published the fifth edition of its guidelines for managing transfusion-dependent β-thalassaemia (TDT), incorporating the latest scientific developments and clinical practices. The updated resource, launched at the 50th Arab Health Medical Expo in Dubai, provides healthcare professionals with evidence-based recommendations for treating this severe genetic haematological condition.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/thalassaemia-1.jpg 360 480 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-13 06:00:162025-02-06 06:55:05Updated guidelines strengthen care standards for transfusion-dependent thalassaemia

Low-cost laparoscope brings minimally invasive surgery to developing nations

, 12 February 2025/in E-News, laparoscopy, Surgery, Sustainability /by panglobal

Scientists have developed an innovative low-cost laparoscope that could dramatically increase access to minimally invasive surgery in developing nations. The device, called KeyScope, delivers comparable imaging performance to standard hospital systems but costs just $1,000 compared to over $130,000 for conventional equipment.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-12 06:00:072025-02-06 06:45:39Low-cost laparoscope brings minimally invasive surgery to developing nations

IV iron in early pregnancy proves safe and effective for anaemia treatment

, 11 February 2025/in E-News, Obs Gyn, Research, Women's Health /by panglobal

A landmark clinical trial conducted across multiple sites in India has demonstrated that administering intravenous iron during early second trimester pregnancy is both safe and effective for treating iron deficiency anaemia, potentially changing current treatment protocols globally.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/pregnant.jpg 907 1361 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-11 06:00:302025-02-06 06:24:33IV iron in early pregnancy proves safe and effective for anaemia treatment
Scientists from Peking University analyzed the proportion of attributable risk factors contributing to early-onset T2D and T2D DALYs in China in 2021, highlighting the role of high BMI and environmental factors.Siyan Zhan, Peking University

Early-onset type 2 diabetes surges among Chinese youth

, 10 February 2025/in Diabetes, E-News, Epidemiology, Research /by panglobal

A comprehensive analysis of early-onset type 2 diabetes (T2D) in China reveals the age-standardised incidence rate has more than doubled between 1990 and 2021, highlighting an urgent public health challenge. The study, published in Health Data Science in December 2024, found particularly concerning trends among adolescents and young males.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/china_diabetes.jpg 700 642 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-10 06:00:032025-02-06 06:17:59Early-onset type 2 diabetes surges among Chinese youth
Analysis from Siemens Financial Services reveals unprecedented healthcare cost surge

Analysis from Siemens Financial Services reveals unprecedented healthcare cost surge

, 7 February 2025/in E-News, Sustainability /by panglobal

Healthcare delivery costs are rising at an unprecedented rate across major economies, significantly outpacing both GDP growth and inflation, according to comprehensive new research from Siemens Financial Services (SFS). The analysis reveals a widening sustainability gap that threatens the fundamental viability of healthcare systems worldwide.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/siemens-costs.jpg 764 1390 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-07 07:00:462025-02-02 07:16:22Analysis from Siemens Financial Services reveals unprecedented healthcare cost surge
Billy Boyle, Owlstone Medical CEO and co-founder

Breath diagnostics firm Owlstone secures £22m funding boost

, 6 February 2025/in Diagnostic tests, E-News /by panglobal

Diagnostic technology company Owlstone Medical has raised $27 million (£22m) in Series E financing to advance its breath-based testing platform for early disease detection, with particular focus on lung cancer, liver disease, and digestive disorders.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/Owlstone-Billy-Boyle-holds-ReCIVA.jpg 1080 1620 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-06 08:00:312025-02-02 07:05:27Breath diagnostics firm Owlstone secures £22m funding boost
da_vinci_surgical_robot

Intuitive Surgical, maker of Da Vinci surgical robots, expands European footprint with strategic distributor acquisition

, 5 February 2025/in E-News, Surgery /by panglobal

Robotic surgery pioneer Intuitive Surgical is set to strengthen its European presence through the acquisition of key distribution businesses across Southern Europe, marking a significant development in the medical technology sector’s regional consolidation.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/02/da_vinci_surgical_robot.jpg 710 1058 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-02-05 08:00:072025-02-02 06:59:25Intuitive Surgical, maker of Da Vinci surgical robots, expands European footprint with strategic distributor acquisition
Page 11 of 235«‹910111213›»

Latest issue of International Hospital

April 2024

1 September 2025

Beta-blocker standard of care challenged by landmark heart attack trial

29 August 2025

SNMMI launches AI-powered trial finder for radiopharmaceuticals

28 August 2025

New non-invasive blood flow test outperforms standard Alzheimer’s diagnostic markers

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription